eXoZymes (EXOZ) Stock Price

eXoZymes Price

NYSE·CLOSED
4.40
​
Market closed

eXoZymes stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

eXoZymes business model & stock analysis

Invizyne Technologies Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Monrovia California, California and currently employs 29 full-time employees. The company went IPO on 2024-11-13. Invizyne Technologies, Inc. is a biotechnology, pre-revenue, development stage company. The firm's cell-free technology expands its ability to perform enzyme-based conversions, guiding towards sustainable biomanufacturing. The firm is primarily engaged in the development of the SimplePath platform. Its SimplePath platform consists of a series of enzyme based biomanufacturing systems that leverage natural processes to perform complex chemical conversions that convert a starting material into a desired end-product. Each SimplePath system is composed of one or more modules which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company can provide solutions for natural ingredients (cannabinoids, flavor enhancers for food and beverage products, fragrances, nutraceuticals, organic compounds), pharmaceuticals (natural products with therapeutic properties) and chemicals (commodity chemicals, specialty chemicals, biofuels).

Frequently asked questions about eXoZymes

Converted at the current exchange rate, the eXoZymes share trades at 3.92 EUR (4.40 USD).

The revenue cannot currently be calculated for eXoZymes.

The expected profit of eXoZymes is -10.00 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of eXoZymes is currently -3.69. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the eXoZymes stock.

The P/S cannot be calculated for eXoZymes currently.

The Eulerpool Quality Score for eXoZymes is 2/10.

The ISIN of eXoZymes is US4618741098. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of eXoZymes is EXOZ. The ticker symbol is used to trade eXoZymes shares on the stock exchange.

Fair ValueTerminal
4.31 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website invizyne.com
Currency
USD
Initial public offering
Nov 13, 2024
ISIN
US4618741098
Cusip
461874109
Market capitalization
36.96 M USDMicro Cap
52-Week Range
PEG
0.15
P/E ratio
P/Ee 2026
-3.69
P/Ee 2027
-3.92
P/Ee 2028
-9.34
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
10.88
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-197.37 %
Last updated Oct 16, 2026, 11:25 PM

eXoZymes Peer Group

All fundamentals and in-depth analysis of eXoZymes

Our stock analysis for eXoZymes stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of eXoZymes. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.